Plug N Play Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 25-06-2024
- Paid Up Capital ₹ 2.00 M
as on 25-06-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -11173.06%
(FY 2022)
- Ebitda -14418.41%
(FY 2022)
- Net Worth -482.32%
(FY 2022)
- Total Assets 102.48%
(FY 2022)
About Plug N Play Biosciences
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Faizal Kuzhilanghattil, Ibnu Kuzhylangattil, Kallivalap Nair, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100MH2021PTC356768
- Company No.
356768
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Plug N Play Biosciences Private Limited offer?
Plug N Play Biosciences Private Limited offers a wide range of products and services, including Pure Herbs, Rosemary Leave, Menthol Essential Aromatic Oil, Rosemary Oleoresin, Ag Oil, Refined Coconut Oil, Cedar Leaf Oil, Niaouli Oil.
Who are the key members and board of directors at Plug N Play Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmesh Shah  | Managing Director | 01-Jun-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Faizal Kuzhilanghattil | Director | 11-Mar-2021 | Current |
| Ibnu Kuzhylangattil | Director | 11-Mar-2021 | Current |
| Kallivalap Nair | Director | 11-Mar-2021 | Current |
Financial Performance of Plug N Play Biosciences.
Plug N Play Biosciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 11173.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 482.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plug N Play Biosciences?
In 2021, Plug N Play Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Portzapp Technology Services Private LimitedActive 1 year 11 monthsFaizal Kuzhilanghattil, Ibnu Kuzhylangattil and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Plug N Play Biosciences?
Plug N Play Biosciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plug N Play Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plug N Play Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
